Benzinga - Thu, 11 Feb 2021 08:20:02 -0400
Benzinga - Wed, 03 Feb 2021 06:09:56 -0400
Benzinga - Mon, 28 Dec 2020 06:00:14 -0400
Benzinga - Mon, 21 Dec 2020 06:05:32 -0400
Benzinga - Tue, 10 Nov 2020 08:11:28 -0400
Benzinga - Thu, 08 Oct 2020 12:48:15 -0400
Benzinga - Mon, 21 Sep 2020 05:17:02 -0400
Benzinga - Fri, 18 Sep 2020 12:15:10 -0400
load more
Sector: Health Care.Industry: Biotechnology
AlloVir Inc is a late clinical-stage cell therapy company. It is developing allogeneic T cell therapies to treat and prevent devastating viral diseases. The firm's pipeline includes ALVR106, ALVR109, ALVR108, and others. The company's product candidate, Viralym-M, is a multi-VST therapy targeting five viruses namely BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, and human herpesvirus 6.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS
(EXPECTED)2021-05-17
REV
Q4 2020Est.ActualSurprise
EPS-1.270
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
ALVRAlloVir-2.8%2.5B

AlloVir Company Questions & Answers

Q

How do I buy AlloVir (ALVR) stock?

A

You can purchase shares of AlloVir (NASDAQ: ALVR) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are AlloVir's (ALVR) main competitors?

A

Other companies in AlloVir’s space includes: Inovio Pharmaceuticals (NASDAQ:INO), OPKO Health (NASDAQ:OPK) and Xencor (NASDAQ:XNCR).

Q

What is the target price for AlloVir?

A

The latest price target for AlloVir (NASDAQ: ALVR) was reported by JP Morgan on 2020-08-24. The analyst firm set a price target for 50.00 expecting ALVR to rise to within 12 months (a possible 24.38% upside). 3 analyst firms have reported ratings in the last year.

Q

How much is AlloVir (ALVR) stock ?

A

The stock price for AlloVir (NASDAQ: ALVR) is $40.2 last updated Thu Feb 25 2021 21:00:02 GMT+0000 (Coordinated Universal Time).

Q

When is the next AlloVir (ALVR) dividend?

A

There are no upcoming dividends for AlloVir.

Q

When is AlloVir (NASDAQ:ALVR) reporting earnings?

A
AlloVir’s Q1 earnings are confirmed after-market from now on May 17, 2021.
Q

When is the upcoming split for ALVR?

A

There is no upcoming split for AlloVir.